NEW YORK, N.Y., USA: Opioid abuse has reached crisis levels across the country, with 44 people dying each day from overdose of opioids and many more becoming addicted. Recognizing the urgency and serious impact of this issue on the health of hundreds of thousands of patients across the country, the American Medical Association (AMA) formed a Task Force to Reduce Opioid Abuse that recently announced the first of several national recommendations to address this growing epidemic.
“As health-care professionals, we’re on the front lines of this issue and see how it causes devastating destruction for every life that it touches,” said ADA President Dr. Maxine Feinberg. “Together, we can harness the collective power of preventative education and intervention to help reverse this epidemic. The ADA stands firmly behind this task force.”
The AMA Task Force to Reduce Opioid Abuse comprises 27 physician organizations including the AMA, the American Osteopathic Association, 17 specialty and seven state medical societies as well as the American Dental Association — all committed to identifying the best practices to combat this public health crisis and move swiftly to implement those practices across the country.
“We have joined together as part of this special task force because we collectively believe that it is our responsibility to work together to provide a clear road map that will help bring an end to this public health epidemic,” said AMA Board Chair-Elect Patrice A. Harris, MD, MA. “We are committed to working long-term on a multi-pronged, comprehensive public health approach to end opioid abuse in America.”
The new initiative will seek to significantly enhance doctors’ education on safe, effective and evidence-based prescribing. This includes a new resource website that houses vital information on prescription drug monitoring programs (PDMPs) and their effectiveness for physician practices, as well as a robust national marketing, social-media and communications campaign to significantly raise awareness of the steps that prescribers can take to combat this epidemic and ensure they are aware of all options available to them for appropriate prescribing.
(Source: ADA)
NEW YORK, NY/WASHINGTON, DC, USA: As Congress prepared to adjourn for its summer recess, the American Dental Association was taking a wait-and-see approach ...
CHICAGO, Ill., USA: The American Dental Association (ADA) today announced a new policy on opioids supporting mandates on prescription limits and continuing ...
CHICAGO, Ill., USA: The American Dental Association (ADA) has launched a new national digital advertising campaign to encourage adults to visit a dentist. ...
WASHINGTON, D.C., USA: The American Dental Association (ADA), the nation’s leading organization of dentists, today announced a nationwide campaign ...
WASHINGTON, D.C., USA: The American Dental Association, Children's Dental Health Project and more than 100 stakeholders want federal legislators to know: ...
PHILADELPHIA, Pa., USA: A two-day “Take a Loved One to the Doctor Health Festival” is planned for Oct. 19 and 20 in Philadelphia. The festival ...
SILVER SPRING, Md., US: The US Food and Drug Administration (FDA) has recently announced that medicines containing buprenorphine that are dissolved under ...
ANN ABOR, Mich., US: Dental opioid prescriptions are associated with an increased risk of opioid overuse, addiction and overdose, and at least 39 US states...
NEWARK, N.J., US: Acute and postoperative dental pain are inevitable, and pain management strategies often include the use of opioids; however, many studies...
NEW YORK, N.Y., USA: The American Dental Hygienists’ Association’s board of trustees recently announced its formal endorsement of the Smiles for...
Live webinar
Thu. 18 July 2024
8:00 PM EST (New York)
Live webinar
Tue. 6 August 2024
6:00 PM EST (New York)
Live webinar
Tue. 13 August 2024
7:00 PM EST (New York)
Live webinar
Wed. 14 August 2024
12:30 PM EST (New York)
Live webinar
Wed. 21 August 2024
9:00 AM EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 PM EST (New York)
Live webinar
Mon. 2 September 2024
5:00 AM EST (New York)
To post a reply please login or register